311 related articles for article (PubMed ID: 34886216)
1. Effects of Mixed of a Ketogenic Diet in Overweight and Obese Women with Polycystic Ovary Syndrome.
Cincione RI; Losavio F; Ciolli F; Valenzano A; Cibelli G; Messina G; Polito R
Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886216
[TBL] [Abstract][Full Text] [Related]
2. Short-time effects of ketogenic diet or modestly hypocaloric Mediterranean diet on overweight and obese women with polycystic ovary syndrome.
Cincione IR; Graziadio C; Marino F; Vetrani C; Losavio F; Savastano S; Colao A; Laudisio D
J Endocrinol Invest; 2023 Apr; 46(4):769-777. PubMed ID: 36401759
[TBL] [Abstract][Full Text] [Related]
3. Effects of a ketogenic diet in overweight women with polycystic ovary syndrome.
Paoli A; Mancin L; Giacona MC; Bianco A; Caprio M
J Transl Med; 2020 Feb; 18(1):104. PubMed ID: 32103756
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the portfolio low-carbohydrate diet and the ketogenic diet in overweight and obese women with polycystic ovary syndrome: study protocol for a randomized controlled trial.
Najafabadi MS; Moludi J; Salimi Y; Saber A
Trials; 2023 Aug; 24(1):509. PubMed ID: 37559131
[TBL] [Abstract][Full Text] [Related]
5. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
7. Does the Ketogenic Diet Improve the Quality of Ovarian Function in Obese Women?
Magagnini MC; Condorelli RA; Cimino L; Cannarella R; Aversa A; Calogero AE; La Vignera S
Nutrients; 2022 Oct; 14(19):. PubMed ID: 36235799
[TBL] [Abstract][Full Text] [Related]
8. Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents.
Calcaterra V; Cena H; Sottotetti F; Hruby C; Madini N; Zelaschi N; Zuccotti G
Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630772
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study.
Mehrabani HH; Salehpour S; Amiri Z; Farahani SJ; Meyer BJ; Tahbaz F
J Am Coll Nutr; 2012 Apr; 31(2):117-25. PubMed ID: 22855917
[TBL] [Abstract][Full Text] [Related]
10. Does a restricted energy low glycemic index diet have a different effect on overweight women with or without polycystic ovary syndrome?
Shishehgar F; Mirmiran P; Rahmati M; Tohidi M; Ramezani Tehrani F
BMC Endocr Disord; 2019 Sep; 19(1):93. PubMed ID: 31477085
[TBL] [Abstract][Full Text] [Related]
11. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.
Silfen ME; Denburg MR; Manibo AM; Lobo RA; Jaffe R; Ferin M; Levine LS; Oberfield SE
J Clin Endocrinol Metab; 2003 Oct; 88(10):4682-8. PubMed ID: 14557441
[TBL] [Abstract][Full Text] [Related]
12. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
13. Obesity and the polycystic ovary syndrome.
Gambineri A; Pelusi C; Vicennati V; Pagotto U; Pasquali R
Int J Obes Relat Metab Disord; 2002 Jul; 26(7):883-96. PubMed ID: 12080440
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
[TBL] [Abstract][Full Text] [Related]
15. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
[TBL] [Abstract][Full Text] [Related]
16. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
17. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
[TBL] [Abstract][Full Text] [Related]
18. Adverse Effects of Selected Markers on the Metabolic and Endocrine Profiles of Obese Women With and Without PCOS.
Daghestani MH; Daghestani MH; Warsy A; El-Ansary A; Omair MA; Omair MA; Hassen LM; Alhumaidhi EM; Al Qahtani B; Harrath AH
Front Endocrinol (Lausanne); 2021; 12():665446. PubMed ID: 34122339
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome.
Wehr E; Möller R; Horejsi R; Giuliani A; Kopera D; Schweighofer N; Groselj-Strele A; Pieber TR; Obermayer-Pietsch B
Wien Klin Wochenschr; 2009; 121(7-8):262-9. PubMed ID: 19562283
[TBL] [Abstract][Full Text] [Related]
20. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
